Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection
Recruiting
N/A
Interventional Study
Elderly
Antibiotics Overuse
Viral Infections
PCR Multiplex
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 256 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Among winter respiratory viruses, influenza is the most common and therefore responsible for the highest mortality, but parainfluenza and RSV viruses have an even higher risk of mortality (1.6 to 1.9 times), this toll being paid mainly by the elderly and co-morbid population. Futhermore, SARS-Cov2 will probably become endemic and/or epidemic with the same targets of fragile patients. These viral i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients ≥ 65 years affiliated to a social security scheme
* Hospitalized for a lower respiratory infection defined as:
* the presence of 2 of the following 4 signs:
* hyperthermia \>38°C,
* hyperleukocytosis ≥12000 or ≤4000,
* purulent aspirations/sputum,
* rales o…
Contacts